Fuji Pharma Co (TSE:4554) EPS (Basic): 円98.86 (TTM As of Mar. 2026)


TSE:4554 Fuji Pharma Co Ltd TSE:4554
86 GF Score
Price 円2,151.00
GF Value 円1,776.28
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fuji Pharma Co EPS (Basic)?

Fuji Pharma Co TSE:4554 -5.49% 86 EPS (Basic) is 円98.86 as of Mar. 2026. GuruFocus rates TSE:4554 with a GF Score™ of 86/100 and a GF Value™ of 円1,776.28 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Fuji Pharma Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was 円15.47. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was 円98.86.

Fuji Pharma Co's EPS (Diluted) for the three months ended in Mar. 2026 was 円15.47. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円98.86.

Fuji Pharma Co's EPS without NRI for the three months ended in Mar. 2026 was 円25.03. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 194.93.

During the past 12 months, Fuji Pharma Co's average EPS without NRIGrowth Rate was 36.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 6.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Fuji Pharma Co's highest 3-Year average EPS without NRI Growth Rate was 25.00% per year. The lowest was -15.30% per year. And the median was 6.40% per year.

Fuji Pharma Co  (TSE:4554) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Fuji Pharma Co EPS (Basic) Related Terms

Fuji Pharma Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Fuji Pharma Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuji Pharma Co EPS (Basic) Chart

Fuji Pharma Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.54 111.01 141.37 252.85 122.94

Fuji Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.08 22.24 47.87 13.28 15.47
TSE:4554
86GF Score
Fuji Pharma Co Ltd TSE:4554
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuji Pharma Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Fuji Pharma Co's Basic EPS for the fiscal year that ended in Sep. 2025 is calculated as

Basic EPS (A: Sep. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3000-0)/24.403
=122.94

Fuji Pharma Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(389-0)/24.805
=15.68

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円98.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of 円98.86 mean?
Fuji Pharma Co (TSE:4554) has a EPS (Basic) of 円98.86 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Fuji Pharma Co and its competitors.
Is Fuji Pharma Co's EPS (Basic) too high?
Fuji Pharma Co's current EPS (Basic) is 円98.86. Overall, Fuji Pharma Co has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fuji Pharma Co's EPS (Basic) compare to ZTS?
Fuji Pharma Co's EPS (Basic) of 円98.86 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Fuji Pharma Co and its competitors. Fuji Pharma Co's current EPS (Basic) is 円98.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuji Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Fuji Pharma Co (TSE:4554) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,776.28, compared to a current price of 円2,151.00 — trading 21.1% above its estimated fair value. The current EPS (Basic) is 円98.86. Fuji Pharma Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Fuji Pharma Co (TSE:4554), the current EPS (Basic) is 円98.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuji Pharma Co (TSE:4554) Overvalued in 2026?

Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued. The current stock price of 円2,151.00 is trading 21.1% above its estimated GF Value™ of 円1,776.28. GuruFocus considers Fuji Pharma Co to be Modestly Overvalued.

Key valuation signals for TSE:4554:

  • EPS (Basic): 円98.86
  • GF Value™: 円1,776.28 vs. price of 円2,151.00 (21.1% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the TSE:4554 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuji Pharma Co Business Description

Address 5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
86GF Score

Get the complete analysis for TSE:4554

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,151.00
Price
円1,776.28
GF Value